Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Bours

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Revue Medicale De Liege|January 21, 2010
[Clinical and genetic characterization of FIPA (familial isolated pituitary adenomas)]A Beckers, P Apetrii, A Daly, et al.
Molecular and Cellular Biology|February 18, 1999
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activityG Bonizzi, J Piette, S Schoonbroodt, et al.
Toxicology|November 25, 2000
NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatmentV Bours, G Bonizzi, M Bentires-Alj, et al.
The Journal of Biological Chemistry|March 24, 1995
Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damagesS Legrand-Poels, V Bours, B Piret, et al.
Cancer Research|February 24, 1999
Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugsM Bentires-Alj, A C Hellin, M Ameyar, et al.
Oncogene|June 3, 1999
Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cellsE Dejardin, V Deregowski, M Chapelier, et al.
Molecular and Cellular Biology|February 1, 1992
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa BR P Ryseck, P Bull, M Takamiya, et al.
Oncogene|July 29, 1998
Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cellsE Dejardin, V Deregowski, R Greimers, et al.
The Journal of Biological Chemistry|June 5, 1998
Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kappaB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich regionP D de Maisieres, L Baudoux-Tebache, M P Merville, et al.
Biological Chemistry|January 13, 1998
Multiple redox regulation in NF-kappaB transcription factor activationJ Piette, B Piret, G Bonizzi, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Revue Medicale De Liege|January 21, 2010
[Clinical and genetic characterization of FIPA (familial isolated pituitary adenomas)]A Beckers, P Apetrii, A Daly, et al.
Molecular and Cellular Biology|February 18, 1999
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activityG Bonizzi, J Piette, S Schoonbroodt, et al.
Toxicology|November 25, 2000
NF-kappaB activation in response to toxical and therapeutical agents: role in inflammation and cancer treatmentV Bours, G Bonizzi, M Bentires-Alj, et al.
The Journal of Biological Chemistry|March 24, 1995
Transcription factor NF-kappa B is activated by photosensitization generating oxidative DNA damagesS Legrand-Poels, V Bours, B Piret, et al.
Cancer Research|February 24, 1999
Stable inhibition of nuclear factor kappaB in cancer cells does not increase sensitivity to cytotoxic drugsM Bentires-Alj, A C Hellin, M Ameyar, et al.
Oncogene|June 3, 1999
Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cellsE Dejardin, V Deregowski, M Chapelier, et al.
Molecular and Cellular Biology|February 1, 1992
RelB, a new Rel family transcription activator that can interact with p50-NF-kappa BR P Ryseck, P Bull, M Takamiya, et al.
Oncogene|July 29, 1998
Regulation of major histocompatibility complex class I expression by NF-kappaB-related proteins in breast cancer cellsE Dejardin, V Deregowski, R Greimers, et al.
The Journal of Biological Chemistry|June 5, 1998
Activation of the human immunodeficiency virus long terminal repeat by varicella-zoster virus IE4 protein requires nuclear factor-kappaB and involves both the amino-terminal and the carboxyl-terminal cysteine-rich regionP D de Maisieres, L Baudoux-Tebache, M P Merville, et al.
Biological Chemistry|January 13, 1998
Multiple redox regulation in NF-kappaB transcription factor activationJ Piette, B Piret, G Bonizzi, et al.
Pageof 11